Phase II study of two dose schedules of C.E.R.A....

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy

Vera Hirsh, John Glaspy, Paul Mainwaring, Christian Manegold, Rodryg Ramlau, Joseph E Eid
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Language:
english
DOI:
10.1186/1745-6215-8-8
Date:
December, 2007
File:
PDF, 327 KB
english, 2007
Conversion to is in progress
Conversion to is failed